Cutaneous Oncology News

When viewing the solar eclipse on April 8, individuals in the United States should not only protect their eyes, but also their skin.

Following a first primary invasive melanoma diagnosis, older adults and men may experience a second case sooner than other patients, according to a study.

Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.

SAN DIEGO — Basal cell carcinoma treatment with jet injection of photodynamic therapy was well tolerated by patients in a pilot study, according to a poster presentation at the American Academy of Dermatology Annual Meeting.

SAN DIEGO — Since 2014 the number of opioid prescribers and prescriptions among Mohs surgeons has decreased, suggesting practices have evolved to avoid dependency, according to a presentation here.

Despite the high cure rate of localized cutaneous melanoma, many patients who undergo successful surgical resection experience severe anxiety and fear about the possibility of recurrence, according to findings published in JAMA Dermatology.

SAN DIEGO — U.S. military members face an increased risk of developing melanoma due to occupational hazards, according to an American Academy of Dermatology press release.

SAN DIEGO — Actor William Shatner still vividly recalls the moment he learned a simple lump under his right ear, initially dismissed, was in fact cancer, and how concern from a caring physician likely saved his life.

SAN DIEGO — The Skin of Color Society has awarded innovation grants to two finalists at the 20th Annual Skin of Color Society Scientific Symposium.

An analysis of global online conversations among health care professionals on social media in February showed an overarching sense of enthusiasm about FDA approval of the first cellular therapy to treat unresectable or metastatic melanoma.